Disclosure of Interests - Mark Bloch
| Year* | Type of relationship | Entity | Comment | Payment received |
|---|---|---|---|---|
| Board membership | ViiV Healthcare; Gilead Sciences; Janssen; Boehringer-Ingelheim; Eli Lilly | Yes | ||
| Consultancy | MSD | HIV consultancy | Yes | |
| Grants / grants pending | ViiV Healthcare; Abbvie; MSD; Janssen; Bristol Myers-Squibb | Yes - Institution only | ||
| Payment for development of educational presentations including service on speaker' bureaus | Eli Lilly | Men's Health | Yes | |
| Payment for development of educational presentations including service on speaker' bureaus | ViiV Healthcare | HIV presentations | Yes | |
| Travel / accommodation expenses covered or reimbursed | ViiV Healthcare; Gilead Sciences; MSD; Boehringer-Ingelheim; Bristol Myers-Squibb; Eli Lilly | Travel to scientific meetings | Yes |
* Information provided for period of 36 months preceding 01 May 2013